Omeprazole

Chemical formula: C₁₇H₁₉N₃O₃S  Molecular mass: 345.416 g/mol  PubChem compound: 4594

Therapeutic indications

Omeprazole is indicated for:

Reflux oesophagitis

Population group: only adults (18 years old or older)

Treatment of reflux oesophagitis.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prevention of relapse of gastric ulcers

Population group: only adults (18 years old or older)

Prevention of relapse of gastric ulcers.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Duodenal ulcer

Population group: only adults (18 years old or older)

Treatment of duodenal ulcers.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Helicobacter pylori eradication in peptic ulcer disease

Population group: only adults (18 years old or older)

Helicobacter pylori eradication in peptic ulcer disease.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Zollinger-Ellison syndrome

Population group: only adults (18 years old or older)

Treatment of Zollinger-Ellison syndrome.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prevention of relapse of duodenal ulcers

Population group: only adults (18 years old or older)

Prevention of relapse of duodenal ulcers.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Gastric ulcer

Population group: only adults (18 years old or older)

Treatment of gastric ulcers.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers

Population group: only adults (18 years old or older)

Treatment of NSAID-associated gastric and duodenal ulcers.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prevention of NSAID-associated gastric and duodenal ulcers in patients at risk

Population group: only adults (18 years old or older)

Prevention of NSAID-associated gastric and duodenal ulcers in patients at risk.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Symptomatic gastro-oesophageal reflux disease

Population group: only adults (18 years old or older)

Treatment of symptomatic gastro-oesophageal reflux disease.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Reflux oesophagitis

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Treatment of reflux oesophagitis.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Helicobacter pylori eradication in peptic ulcer disease

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Helicobacter pylori eradication in peptic ulcer disease.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Omeprazole is contraindicated in the following cases:

Nelfinavir

Nelfinavir

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.